Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotropins.
Hypersensitivity reactions are a documented complication of urinary-derived gonadotropin therapy. In this report, a patient allergic to these older products is successfully treated with recombinant follicle-stimulating hormone.
Whitman-Elia
G F
GF
Department of Obstetrics and Gynecology, University of South Carolina School of Medicine, Columbia 29203, USA.
Banks
K
K
O'Dea
L S
LS
D000328:Adult; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage* / Q000009:adverse effects*; D006062:Gonadotropins / Q000009:adverse effects*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects
D006062:Gonadotropins; D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone